on these activities, see Note 2 (Trading Activities).
(2)
Includes securities with a fair value of $
369
million and $
590
million at March 31, 2025, and December 31, 2024, respectively, subject to contractual lock-up periods restricting the sale of the securities, the majority of which expire in second quarter 2025.
(3)
Includes affordable housing investments of $
11.9
billion and $
12.3
billion at March 31, 2025, and December 31, 2024, respectively, and renewable energy investments of $
9.1
billion and $
9.4
billion at March 31, 2025, and December 31, 2024, respectively. Tax credit investments are accounted for using either the proportional amortization method or the equity method. See Note 13 (Securitizations and Variable Interest Entities) for information about tax credit investments.
(4)
Includes equity securities accounted for under the measurement alternative of $
9.2
billion and $
9.3
billion at March 31, 2025, and December 31, 2024, respectively, which were predominantly securities associated with our venture capital investments. The remaining securities are accounted for using the equity method.
(5)
Includes $
3.5
billion of investments in Federal Reserve Bank stock at both March 31, 2025, and December 31, 2024, and $
43
million and $
224
million of investments in Federal Home Loan Bank stock at March 31, 2025, and December 31, 2024, respectively.
Net Gains and Losses Not Held for Trading
Table 4.2 provides a summary of the net gains and losses from equity securities not held for trading, which excludes equity method adjustments for our share of the investee’s earnings or
losses that are recognized in other noninterest income. Gains and losses for securities held for trading are reported in net gains from trading and securities.
Table 4.2:
Net Gains (Losses) from Equity Securities Not Held for Trading
(1)
Includes amounts related to venture capital investments in consolidated portfolio companies, which are not reported in equity securities on our consolidated balance sheet.
(2)
Includes unrealized gains (losses) due to observable price changes from equity securities accounted for under the measurement alternative.
Note 4:
Equity Securities
(continued)
Measurement Alternative
Table 4.3 provides additional information about the impairment write-downs and observable price changes from nonmarketable equity securities accounted for under the measurement alternative. Gains and losses related to these adjustments are also included in Table 4.2.
Table 4.3:
Net Gains (Losses) from Measurement Alternative Equity Securities
Table 4.4 presents cumulative carrying value adjustments to nonmarketable equity securities accounted for under the measurement alternative that were still held at the end of each reporting period presented.
Table 4.4:
Measurement Alternative Cumulative Gains (Losses)
Table 5.1 presents total loans outstanding by portfolio segment and class of financing receivable. Loans are reported at their outstanding principal balances net